Terms: = Kidney tumors AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Prognosis
29 results:
1. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
; ; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
[TBL] [Abstract] [Full Text] [Related]
2. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: A review.
Zhang H; Hu Z; Wang S; Wu K; Yang Q; Song X
Medicine (Baltimore); 2022 Dec; 101(52):e32492. PubMed ID: 36596036
[TBL] [Abstract] [Full Text] [Related]
3. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
Touraine R; Hauet Q; Harzallah I; Baruteau AE
Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
[TBL] [Abstract] [Full Text] [Related]
4. [CK7+/CD117- low grade oncocytic tumor of the kidney: a clinicopathological analysis].
Bai YF; Chang CD; Wang B; Zhao M; Teng XD
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):976-980. PubMed ID: 36207909
[No Abstract] [Full Text] [Related]
5. A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma.
Wang Z; Liu X; Wang W; Wei J; Seery S; Xu J; Sun H; Yu Y; Zhao Y; Wang X; Liao Z; Li Y; Sun W; Jia L; Zhang Y
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36111504
[TBL] [Abstract] [Full Text] [Related]
6. Renal Neoplasia in Polycystic kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/tsc2 Contiguous Gene Deletion Syndrome.
Gupta S; Lohse CM; Rowsey R; McCarthy MR; Shen W; Herrera-Hernandez L; Boorjian SA; Houston Thompson R; Jimenez RE; Leibovich BC; Cheville JC
Eur Urol; 2022 Mar; 81(3):229-233. PubMed ID: 34876325
[TBL] [Abstract] [Full Text] [Related]
7. Eosinophilic Solid and Cystic Renal Cell Carcinoma With Melanin Pigment-Expanding the Morphological Spectrum.
Aldera AP; Hes O
Int J Surg Pathol; 2022 May; 30(3):295-299. PubMed ID: 34402332
[TBL] [Abstract] [Full Text] [Related]
8. [Tuberous sclerosis complex: analysis of areas of involvement, treatment progress and translation to routine clinical practice in a cohort of paediatric patients].
Cantarín-Extremera V; Bernardino-Cuesta B; Martín-Villaescusa C; Melero-Llorente J; Hernández-Martín A; Aparicio-López C; de Lucas-Collantes C; Tamariz Martel-Moreno A; Duat-Rodríguez A; Ruiz-Falcó-Rojas ML
Rev Neurol; 2021 Sep; 73(5):141-150. PubMed ID: 34328203
[TBL] [Abstract] [Full Text] [Related]
9. Low-Grade Oncocytic Tumor of kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics.
Kravtsov O; Gupta S; Cheville JC; Sukov WR; Rowsey R; Herrera-Hernandez LP; Lohse CM; Knudson R; Leibovich BC; Jimenez RE
Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838
[TBL] [Abstract] [Full Text] [Related]
10. [Pulmonary lymphangioleiomyomatosis (lam)].
Theegarten D; Hager T
Pathologe; 2021 Feb; 42(1):35-39. PubMed ID: 33420570
[TBL] [Abstract] [Full Text] [Related]
11. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.
Roldan-Romero JM; Santos M; Lanillos J; Caleiras E; Anguera G; Maroto P; García-Donas J; de Velasco G; Martinez-Montes ÁM; Calsina B; Monteagudo M; Letón R; Leandro-García LJ; Montero-Conde C; Cascón A; Robledo M; Rodriguez-Antona C
Mod Pathol; 2020 Dec; 33(12):2580-2590. PubMed ID: 32616874
[TBL] [Abstract] [Full Text] [Related]
12. [Eosinophilic solid and cystic renal cell carcinoma: clinicopathological analysis and molecular characterization].
Xia QY; Wang X; Wei X; Wang XT; Ma HH; Lu ZF; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2019 Nov; 48(11):840-845. PubMed ID: 31775431
[No Abstract] [Full Text] [Related]
13. Lymphangioleiomyomatosis.
Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
[TBL] [Abstract] [Full Text] [Related]
14. Modeling Renal Cell Carcinoma in Mice:
Gu YF; Cohn S; Christie A; McKenzie T; Wolff N; Do QN; Madhuranthakam AJ; Pedrosa I; Wang T; Dey A; Busslinger M; Xie XJ; Hammer RE; McKay RM; Kapur P; Brugarolas J
Cancer Discov; 2017 Aug; 7(8):900-917. PubMed ID: 28473526
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathologic features of renal epithelioid angiomyolipoma: report of one case and review of literatures.
Tan G; Liu L; Qiu M; Chen L; Cao J; Liu J
Int J Clin Exp Pathol; 2015; 8(1):1077-80. PubMed ID: 25755823
[TBL] [Abstract] [Full Text] [Related]
16. Oncotargets in different renal cancer subtypes.
Moch H; Montironi R; Lopez-Beltran A; Cheng L; Mischo A
Curr Drug Targets; 2015; 16(2):125-35. PubMed ID: 25619751
[TBL] [Abstract] [Full Text] [Related]
17. Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases.
Sciacca P; Giacchi V; Mattia C; Greco F; Smilari P; Betta P; Distefano G
BMC Cardiovasc Disord; 2014 May; 14():66. PubMed ID: 24884933
[TBL] [Abstract] [Full Text] [Related]
18. Coexistence of tuberous sclerosis complex and malignant melanoma.
Günaldi M; Paydas S; Afsar CU; Doran F
Singapore Med J; 2013 Nov; 54(11):e233-5. PubMed ID: 24276112
[TBL] [Abstract] [Full Text] [Related]
19. Reduction in size of renal angiomyolipoma after treatment with everolimus in lung transplantation due to lymphangioleiomyomatosis.
Bujalance-Cabrera C; Vaquero-Barrios JM; Redel-Montero J; Caballero-Ballesteros L; Requejo-Jiménez A; Santos-Luna F
Arch Bronconeumol; 2012 Dec; 48(12):479-81. PubMed ID: 22444789
[TBL] [Abstract] [Full Text] [Related]
20. Clinical features of lymphangioleiomyomatosis complicated by renal angiomyolipomas.
Mizushina Y; Bando M; Hosono T; Mato N; Nakaya T; Ishii Y; Yamasawa H; Sugiyama Y
Intern Med; 2011; 50(4):285-9. PubMed ID: 21325759
[TBL] [Abstract] [Full Text] [Related]
[Next]
